Matt Asay recently posted on cnet that the clinical trial open source project OpenClinica has finally broken through. TMCnet gives a great profile of the open source project:
“Since its debut in 2005, OpenClinica [developed by Akaza Research] has quickly become the most popular open source clinical trials software in the world. Akaza Research previously announced that it had experienced 2,000 OpenClinica downloads as of August 2006. Today's announcement represents a growth of 700 percent since that time....Akaza Research takes the position that its professional open source approach is key to helping to facilitate widespread adoption.”
This is a very interesting concept for the clinical trials industry, but I’m eager to see if this concept will catch on with big pharma execs.
Monday, December 1, 2008
Subscribe to:
Post Comments (Atom)
1 comment:
Post a Comment